Takeda To Highlight Rozerem Melatonin Receptor Mechanism Of Action
Takeda's Rozerem promotions will highlight ramelteon's melatonin receptor activity and lack of abuse potential following FDA approval of the insomnia therapy
Takeda's Rozerem promotions will highlight ramelteon's melatonin receptor activity and lack of abuse potential following FDA approval of the insomnia therapy